Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces

FEMS Microbiology Letters

Volumn 235, Issue 1, 2004, Pages 65-72

  Lepercq, Pascale ^a   Gérard, Philippe ^a   Béguet, Fabienne ^a   Raibaud, Pierre ^a   Grill, Jean Pierre ^b   Relano, Purification ^c   Cayuela, Chantal ^c   Juste, Catherine ^a  

^a CEMAGREF   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Grp Probiotiques Fonctions D   (France)

Author keywords

Bile acid epimerization; Chenodeoxycholic acid; Clostridium baratii; Human intestinal microbiota; Ursodeoxycholic acid

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; RIBOSOME DNA; URSODEOXYCHOLIC ACID;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHEMICAL ANALYSIS; CLOSTRIDIUM; CLOSTRIDIUM BARATII; CONJUGATION; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; EPIMERIZATION; FECES; HUMAN; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AGED; CHENODEOXYCHOLIC ACID; CLOSTRIDIUM; FECES; HUMANS; ISOMERISM; MALE; URSODEOXYCHOLIC ACID;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM BARATII; MICROBIOTA;

EID: 2442678019     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.04.011     Document Type: Article

References (48)

1. Woollett L.A., Buckley D.D., Yao L., Jones P.J.H., Granholm N.A., Tolley E.A., Heubi J.E. Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. J. Lipid. Res. 44:2003;935-942
2. van Gorkom B.A., van der Meer R., Boersma-van Ek W., Termont D.S., de Vries E.G., Kleibeuker J.H. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers. Scand. J. Gastroenterol. 37:2002;965-971
3. Bachrach W.H., Hofmann A.F. Ursodeoxycholic acid treatment of cholesterol cholelithiasis. Dig. Dis. Sci. 24:1982;833-856
4. Colombo C., Setchell K.D.R., Podda M., Crosignani A., Roda A., Curcio L., Ronchi M., Giunta A.N. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J. Pediatr. 117:1990;482-489
5. Podda M., Ghezzi C., Battezzati P.M., Crosignani A., Zuin M., Roda A. Effects of ursodeoxycholic acid in taurine on serum liver enzymes and bile acids in chronic hepatitis. Gastroenterology. 98:1990;1044-1050
6. Combes B., Carithers R.L., Maddrey W.C., Lin D., McDonald M.F., Wheeler D.E., Eifenbrodt E.H., Munoz S.J., Rubin R., Garcia-tsao G. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 22:1995;759-766
7. Earnest D.L., Holubec H., Wali R.K., Jolley C.S., Bissonette M., Bhattacharyya A.K., Roy H., Khare S., Brasitus T.A. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemented dietary ursodeoxycholic acid. Cancer Res. 54:1994;5071-5074
8. Batta A.K., Salen G., Holubec H., Brasitus T.A., Alberts D., Earnest D.L. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Cancer Res. 58:1998;1684-1687
9. Wali R.K., Stoiber D., Nguyen L., Hart J., Sitrin M.D., Brasitus T., Brissonette M. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol. Biomarkers Prev. 11:2002;1316-1321
10. Oyama K., Shiota G., Ito H., Murawaki Y., Kawasaki H. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis. 23:2002;885-892
11. Keene C.D., Rodrigues C.M.P., Eich T., Chhabra M.S., Steer C.J., Low W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc. Natl. Acad. Sci. USA. 99:2002;10671-10676
12. Yoshimoto T., Higashi H., Kanatani A., Lin X.S., Nagai H., Oyama H., Kurazono K., Tsuru D. Cloning and sequencing of the 7α-hydroxysteroid dehydrogenase gene from Escherichia coli HB 101 and characterization of the expressed enzyme. J. Bacteriol. 173:1991;2173-2179
13. Baron S.F., Franklund C.V., Hylemon P.B. Cloning, sequencing, and expression of the gene coding for bile acid 7α-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708. J. Bacteriol. 173:1991;4558-4569
14. Coleman J.P., Hudson L.L., Adams M.J. Characterization and regulation of the NADP-linked 7 alpha-hydroxysteroid dehydrogenase gene from Clostridium sordellii. J. Bacteriol. 176:1994;4865-4874
15. Bennett M.J., McKnight S.L., Coleman J.P. Cloning and characterization of the NAD-dependent 7α-hydroxysteroid dehydrogenase from Bacteroides fragilis. Curr. Microbiol. 47:2003;475-484
16. Akao T., Akao T., Kobashi K. Purification and characterization of 7β-hydroxysteroid dehydrogenase from Ruminococcus sp. of human intestine. J. Biochem. 102:1987;613-619
17. Macdonald I.A., White B.A., Hylemon P.B. Separation of 7α- and 7β-hydroxysteroid dehydrogenase activities from Clostridium absonum ATCC# 27555 and cellular response of this organism to bile acid inducers. J. Lipid Res. 24:1983;1119-1126
18. Masuda N., Oda H., Tanaka H. Purification and characterization of NADP-dependent 7 beta-hydroxysteroid dehydrogenase from Peptostreptococcus productus strain b-52. Biochim. Biophys. Acta. 755:1983;65-69
19. Macdonald I.A., Hutchison D.M., Forrest T.P. Formation of urso- and ursodeoxy-cholic acids from primary bile acids by Clostridium absonum. J. Lipid Res. 22:1981;458-466
20. Sutherland J.D., Holdeman L.V., Williams C.N., Macdonald I.A. Formation of urso- and urso-deoxycholic acids from primary bile acids by a Clostridium limosum soil isolate. J. Lipid Res. 25:1984;1084-1089
21. Dean M., Fantin G., Fogagnolo M., Medici A., Pedrini P., Poli S. Microbial 7-OH epimerisation of bile acids. Chem. Lett. 7:1999;693-694
22. Fedorowski T., Salen G., Tint G.S., Mosbach E.H. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology. 77:1979;1068-1073
23. Hirano S., Masuda N., Oda H. In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal microbiota, with particular reference to mutual conversion between the two bile acids. J. Lipid Res. 22:1981;735-743
24. Salen G., Tint G.S., Eliav B., Deering N., Mosbach E.H. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid. J. Clin. Invest. 53:1974;612-621
25. Hirano S., Masuda N. Epimerization of the 7-hydroxy group of bile acids by the combination of two kinds of microorganisms with 7α- and 7β-hydroxysteroid dehydrogenase activity, respectively. J. Lipid Res. 22:1981;1060-1068
26. Macdonald I.A., Rochon Y.P., Hutchison D.M., Holdeman L.V. Formation of ursodeoxycholic acid from chenodeoxycholic acid by a 7β-hydroxysteroid dehydrogenase-elaborating Eubacterium aerofaciens strain cocultured with 7α-hydroxysteroid dehydrogenase-elaborating organisms. Appl. Environ. Microbiol. 44:1982;1187-1195
27. Edenharder R., Knaflic T. Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by human intestinal lecithinase-lipase-negative Clostridia. J. Lipid Res. 22:1981;652-658
28. Legakis N.J., Ioannides H., Tzannetis S., Golematis B., Papavassiliou J. Faecal bacterial flora in patients with colon cancer and control subjects. Zentralbl. Bakteriol. Mikrobiol. Hyg. 251, 1981;54-61
29. Kubota Y. Fecal intestinal flora in patients with colon adenoma and colon cancer. Nippon Shokakibyo Gakkai Zasshi. 87:1990;771-779
30. Kanazawa K., Konishi F., Mitsuoka T., Terada A., Itoh K., Narushima S., Kumemura M., Kimura H. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer. 77(8 Suppl):1996;1701- 1706
31. Eneroth, P. and Sjövall J. (1971) Extraction, purification, and chromatographic analysis of bile acids in biological materials. In: The Bile Acids: Chemistry, Physiology, and Metabolism (Nair, P.P., Kritchevsky, D., Eds.), Vol. 1, pp. 121-171. Plenum Press, New Yorks
32. Dore J., Sghir G., Hannequart-Gramet G., Corthier G., Pochart P. Design and evaluation of a 16S rRNA-targeted oligonucleotide probe for specific detection and quantitation of human faecal Bacteroides populations. Syst. Appl. Microbiol. 21:1998;65-71
33. Collins M.D., Lawson P.A., Willems A., Cordoba J.J., Fernandez-Garayzabal J., Garcia P., Cai J., Hippe H., Farrow J.A.E. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:1994;812-826
34. Hayase M., Mitsui N., Tamay K., Nakamura S., Nishida S. Isolation of Clostridium absonum and its cultural and biochemical properties. Infect. Immun. 9:1974;15-19
35. Tamura M., Hirayama K., Itoh K. Comparison of colonic bacterial enzymes in gnotobiotic mice monoassociated with different intestinal bacteria. Microb. Ecol. Health Dis. 9:1996;287-294
36. Hayashi H., Sakamoto M., Benno Y. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol. Immunol. 46:2002;535-548
37. Wang X., Heazlewood S.P., Krause D.O., Florin T.H. Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J. Appl. Microbiol. 95:2003;508-520
38. Franks A.H., Harmsen H.J., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 64:1998;3336-3345
39. Fromm H., Sarva R.P., Bazzoli F. Formation of ursodeoxycholic acid from chenodeoxycholic acid in the human colon: studies of the role of 7-ketolithocholic acid as an intermediate. J. Lipid Res. 24:1983;841-853
40. Invernizzi P., Setchell K.D.R., Crosignani A., Battezzati P.M., Larghi A., O'Connell N.C., Podda M. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology. 29:1999;320-327
41. Gustafsson B.E., Midtvedt T., Norman A. Metabolism of cholic acid in germfree animals after the establishment in the intestinal tract of deconjugating and 7α-dehydroxylating bacteria. Acta Pathol. Microbiol. Scand. 72:1968;433-443
42. Batta A.K., Salen G., Arora R., Shefer S., Batta M., Person A. Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J. Biol. Chem. 265:1990;10925-10928
43. Sutherland J.D., Williams C.N. Bile acid induction of 7α- and 7β-hydroxysteroid dehydrogenases in Clostridium limosum. J. Lipid Res. 26:1985;344-350
44. Edenharder R., Pfützner M., Hammann R. NADP-dependent 3β-, 7α- and 7β-hydroxysteroid dehydrogenase activities from a lecithinase-lipase-negative Clostridium species 25.1.c. Biochim. Biophys. Acta. 1002:1989;37-44
45. Hylemon P.B., Stellwag E.J. Bile acid biotransformation rates of selected gram-positive and gram-negative intestinal anaerobic bacteria. Biochem. Biophys. Res. Commun. 69:1976;1088-1094
46. Gilliland S.E., Speck M.L. Deconjugation of bile acids by intestinal lactobacilli. Appl. Environ. Microbiol. 33:1977;15-18
47. Kobashi K., Nishizawa I., Yamada T., Hase J. A new hydrolase specific for taurine-conjugates of bile acids. J. Biochem. 84:1978;495-497
48. Kawamoto K., Horibe I., Uchida K. Purification and characterization of a new hydrolase for conjugated bile acids, chenodeoxycholyltaurine hydrolase, from Bacteroides vulgatus. J. Biochem. 106:1989;1049-1053